Galapagos | Attività



Assets Cambiamento Data
AstraZeneca USD 106.25B 2.22B 2025-03
Biogen USD 28.03B 16.2M 2025-03
Genmab DKK 45.81B 6.15B 2024-12
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
GRIFOLS EUR 21.41B 1.12B 2024-12
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Incyte USD 5.75B 305.04M 2025-03
Merck EUR 51.57B 1.42B 2024-12
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
UCB EUR 17.35B 1.72B 2024-12
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



Galapagos Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.